In contrast to mice with congenital GCGR−/−, mice with an inducible GCGR−/− knockdown treated with STZ have only partial protection from hyperglycaemia (Rivero-Gutierrez et al. 2018). The gene discussed is GCGR; the disease is Hyperglycemia.